Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Efficacy of Durvalumab Plus Tremelimumab in Chinese NSCLC Patients: Phase 3 NEPTUNE China Cohort Mar 03, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Significant DFS Benefit with Adjuvant Osimertinib in EGFR-Mutated NSCLC - Phase 3 ADAURA Trial Mar 03, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) IrAEs and Atezolizumab Efficacy in Advanced NSCLC: Pooled Analysis Mar 03, 2023
Head & Neck Cancer,Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Study Shows TAK-788 Improves QoL & Symptoms in Previously Treated Metastatic NSCLC Patients Feb 27, 2023
Lung Cancer,Popular,SCLC (Small Cell Lung Cancer) Clinical Outcomes with High-Dose Once-Daily Thoracic Radiotherapy Feb 24, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),Popular KEYNOTE-407 Study: Pembrolizumab Plus Chemo in Squamous NSCLC Feb 16, 2023
